Amneal Pharmaceuticals Inc. Class A (AMRX) Fundamentals

Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals, and the Specialty segment is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies.
SHARE INFORMATION
Market Cap$ 465,994,409
Shares Outstanding150,807,252
Float102,194,090
Percent Float67.76%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 2,093,669,000
Latest Fiscal EPS$ 0.07
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions348
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months4,378,003
Institutional Holdings Percent97.0%
Institutional Sold Previous 3 Months9,058,794
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months1,022,228
Insider Holdings Percent2.7
Insider Sold Previous 3 Months372,878
Insider Shares Owned4,004,470
TRADING INFO
52 Week High$ 5.99
52 Week Low$ 2.90
52 Week High Change$ -39.88
21 Day Moving Average$ 3.3295
21 Day Extended Moving Average$ 3.3404
50 Day Moving Average$ 3.3114
50 Day Extended Moving Average$ 3.3877
200 Day Moving Average$ 4.1175
200 Day Extended Moving Average$ 3.9947
10 Day Average Volume990,312
20 Day Average Volume785,006
30 Day Average Volume704,166
50 Day Average Volume698,815
Alpha-0.026477
Beta1.1786
Standard Deviation0.154392
R20.145784
7 Day Price Change$ -0.53
7 Day Percent Change-14.64%
21 Day Price Change$ -0.19
21 Day Percent Change-5.79%
30 Day Price Change$ -0.21
30 Day Percent Change-6.36%
Month to Date Price Change$ -0.45
Month to Date Percent Change-12.71%
Quarter to Date Price Change$ -0.09
Quarter to Date Percent Change-2.83%
180 Day Price Change$ -1.78
180 Day Percent Change-36.55%
200 Day Price Change$ -1.37
200 Day Percent Change-30.72%
Year to Date Price Change$ -1.70
Year to Date Percent Change-35.49%

Amneal Pharmaceuticals Inc. Class A (AMRX) Key Ratios

PROFITABILITY
EBIT Margin6.8%
EBITDA Margin18.0%
Pre-Tax Profit Margin-2.8%
Profit Margin Count-2.11%
Gross Margin35.8%
Profit Margin TOT-2.11%
INCOME STATEMENTS
Revenue$ 1,563,122,000
Revenue Per Share$ 10.3239
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-0.30
Total Debt To Equity7.30
Int Coverage1.00
Current Ratio2.30
Leverage Ratio10.40
Quick Ratio1.40
Long Term Debt To Capital0.88
VALUATION MEASURES
PE Ratio156.50
Enterprise Value$ 3,278,775,698
Price to Sales0.299306
Price to Free Cash7.30
PE High Last 5 Years0.00
Price To Book2.70
Price To Cash Flow3.40
PE Low Last 5 Years0.00
Price to Tangible Book-0.30
MANAGEMENT EFFECTIVENESS
Receivables Turnover1.00
Invoice Turnover2.60
Assets Turnover0.20
Return Assets0.04
Return on Equity0.49
Return on Capital2.56

Amneal Pharmaceuticals Inc. Class A (AMRX) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorErnst & Young LLP
CEOChintu Patel / Chirag Patel
Emplyoees7200
Last AuditUQ
CIK0001723128
IndustryDrug Manufacturers
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address400 Crossing Boulevard
3rd Floor
Bridgewater, NJ 8807
Websitehttps://www.amneal.com
Facsimile+1 908 947-3146
Telephone+1 908 947-3120
EmailInvest@amneal.com
Your Recent History
NYSE
AMRX
Amneal Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20220810 22:53:12